---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-080662"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:49:14.255291+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InMed receives Nasdaq delisting notice for bid price non-compliance; hearing set for Oct 31, 2024

## Summary
- Nasdaq Staff issued delisting notice on Sept 17, 2024, after company failed to meet minimum $1.00 bid price by Sept 16, 2024 compliance deadline.
- Company timely filed an appeal; hearing before Nasdaq Listing Qualifications Panel scheduled for October 31, 2024.
- Appeal stays delisting pending panel decision; panel may grant up to 180 additional calendar days to regain compliance.
- No guarantee extension will be granted or that outcome will be favorable; shares risk suspension or delisting.
- Previously received 180-day extension on March 19, 2024 to cure deficiency.

## SEC filing metadata
- accession: 0001213900-24-080662
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390024080662/0001213900-24-080662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390024080662/ea0215298-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-080662
- JSON: https://secwatch.observer/filing/0001213900-24-080662.json
- Plain text: https://secwatch.observer/filing/0001213900-24-080662.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.